跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHOSLO TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PHOSLO TABLETS
Authorized
STANDARD
PHOSLO TABLETS
Fresenius USA Manufacturing, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fee45ceb23a35030
Company
Fresenius USA Manufacturing, Inc.
Type
Standard
Approval Details
Approval Id
fee45ceb23a35030
Drug Approval Canada Name
PHOSLO TABLETS
Product Name
PHOSLO TABLETS
Status
Cancelled Post Market
Status Date
2013-07-29
Original Market Date
2006-02-22
Din
02229437
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:18.19
Atc Original
V03AE DRUGS FOR TREATMENT OF HYPERKALEMIA AND HYPERPHOSPHATEMIA
Atc Name
v 03 ae
Aig Number
0123586005
Company Name
Fresenius USA Manufacturing, Inc.
Company Address
920 Winter Street, Waltham, Massachusetts, United States, 02451-1457
Company Detail Path
/organization/fresenius-usa-manufacturing-inc
Company Information
Pharmaceutical Company Name
Fresenius USA Manufacturing, Inc.
Country Name
United States
Province Name
Massachusetts
City Name
waltham,massachusetts,country_us
Address
920 Winter St
Active Ingredients
CALCIUM ACETATE
667 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fee45ceb23a35030
Type
Standard
Back to Health Canada Approvals